Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOCICLIB Cause Obstructive airways disorder? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Obstructive airways disorder have been filed in association with RIBOCICLIB (KISQALI). This represents 0.0% of all adverse event reports for RIBOCICLIB.

8
Reports of Obstructive airways disorder with RIBOCICLIB
0.0%
of all RIBOCICLIB reports
1
Deaths
6
Hospitalizations

How Dangerous Is Obstructive airways disorder From RIBOCICLIB?

Of the 8 reports, 1 (12.5%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Obstructive airways disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOCICLIB Cause?

Neutropenia (3,585) Nausea (3,404) Fatigue (3,327) Malignant neoplasm progression (2,468) Death (2,452) Vomiting (1,953) Diarrhoea (1,830) White blood cell count decreased (1,683) Pain (1,637) Metastases to bone (1,538)

What Other Drugs Cause Obstructive airways disorder?

ALBUTEROL (4,195) TIOTROPIUM (2,634) PREDNISONE (2,480) BUDESONIDE\FORMOTEROL (2,210) MONTELUKAST (2,073) MEPOLIZUMAB (1,883) OMALIZUMAB (1,670) CICLESONIDE (1,403) FLUTICASONE\SALMETEROL (1,253) BUDESONIDE (1,214)

Which RIBOCICLIB Alternatives Have Lower Obstructive airways disorder Risk?

RIBOCICLIB vs RIBOFLAVIN RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE RIBOCICLIB vs RIFABUTIN RIBOCICLIB vs RIFAMPICIN

Related Pages

RIBOCICLIB Full Profile All Obstructive airways disorder Reports All Drugs Causing Obstructive airways disorder RIBOCICLIB Demographics